Treatment with 1,1-diarylethylene (NB73), a small FOXM1 inhibitory compound, suppresses MM in vitro and in vivo by enhancing the proteasomal degradation of FOXM1 (41). This evidence concerns the gene FOXM1 and Miyoshi myopathy.